Dogwood Therapeutics, Inc. (DWTX) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $2.76
• Market Cap: $92.08M
• EPS: $-25.59
• 52-Week High: $14.69
• 52-Week Low: $2.60

About Dogwood Therapeutics, Inc.

Dogwood Therapeutics, Inc. is a forward-thinking biotechnology company based in Alpharetta, Georgia, focused on pioneering antiviral therapies aimed at addressing diseases stemming from dysregulated immune responses to viral infections. With a promising pipeline of innovative therapeutic candidates, the company utilizes cutting-edge research to redefine treatment strategies in the field. As it progresses through the preclinical and clinical development phases, Dogwood Therapeutics is dedicate...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Dogwood Therapeutics, Inc. and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does DWTX pay dividends?

Dogwood Therapeutics, Inc. (DWTX) does not currently pay a regular dividend.

What is DWTX's market cap?

Dogwood Therapeutics, Inc. (DWTX) has a market capitalization of $92.08M with a current stock price of $2.76.